Get started
SHANGHAI MICROPORT MEDBOT (GROUP) CSHANGHAI MICROPORT MEDBOT (GROUP) CSHANGHAI MICROPORT MEDBOT (GROUP) C

SHANGHAI MICROPORT MEDBOT (GROUP) C

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

2252 chart


Full chart

2252 upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪17.23 B‬ HKD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.70 HKD
Net income (FY)
‪−696.51 M‬ HKD
Revenue (FY)
‪278.92 M‬ HKD
Shares float
‪382.57 M‬
Beta (1Y)
2.14

Employees


Employees (FY)
450
Change (1Y)
−200 −30.77%
Revenue / Employee (1Y)
‪619.81 K‬ HKD
Net income / Employee (1Y)
‪−1.55 M‬ HKD

About SHANGHAI MICROPORT MEDBOT (GROUP) C


Sector
Health Technology
Industry
Medical Specialties
Website
medbotsurgical.com
Headquarters
Shanghai
Founded
2015
ISIN
CNE100004QP1
FIGI
BBG011DL0RD1
Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, manufacturing, and sale of surgical robots. Its product portfolio covers surgical specialties of laparoscopic, orthopedic, panvascular, natural orifice, and percutaneous surgical procedures. Its products include Toumai, DFVision, and SkyWalker. The company was founded on May 11, 2015 and is headquartered in Shanghai, China.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

2252 news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as 2252.

Frequently Asked Questions


The current price of 2252 is 16.88 HKD — it has decreased by −0.58% in the past 24 hours. Watch SHANGHAI MICROPORT MEDBOT (GROUP) C stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange SHANGHAI MICROPORT MEDBOT (GROUP) C stocks are traded under the ticker 2252.
2252 stock has risen by 9.46% compared to the previous week, the month change is a −6.35% fall, over the last year SHANGHAI MICROPORT MEDBOT (GROUP) C has showed a 27.49% increase.
We've gathered analysts' opinions on SHANGHAI MICROPORT MEDBOT (GROUP) C future price: according to them, 2252 price has a max estimate of 20.28 HKD and a min estimate of 15.50 HKD. Watch 2252 chart and read a more detailed SHANGHAI MICROPORT MEDBOT (GROUP) C stock forecast: see what analysts think of SHANGHAI MICROPORT MEDBOT (GROUP) C and suggest that you do with its stocks.
2252 reached its all-time high on Nov 16, 2021 with the price of 73.44 HKD, and its all-time low was 6.04 HKD and was reached on Sep 11, 2024. View more price dynamics on 2252 chart.
See other stocks reaching their highest and lowest prices.
2252 stock is 2.61% volatile and has beta coefficient of 2.14. Track SHANGHAI MICROPORT MEDBOT (GROUP) C stock price on the chart and check out the list of the most volatile stocks — is SHANGHAI MICROPORT MEDBOT (GROUP) C there?
Today SHANGHAI MICROPORT MEDBOT (GROUP) C has the market capitalization of ‪17.23 B‬, it has decreased by −7.73% over the last week.
Yes, you can track SHANGHAI MICROPORT MEDBOT (GROUP) C financials in yearly and quarterly reports right on TradingView.
SHANGHAI MICROPORT MEDBOT (GROUP) C is going to release the next earnings report on Aug 27, 2025. Keep track of upcoming events with our Earnings Calendar.
2252 net income for the last half-year is ‪−396.22 M‬ HKD, while the previous report showed ‪−300.34 M‬ HKD of net income which accounts for −31.93% change. Track more SHANGHAI MICROPORT MEDBOT (GROUP) C financial stats to get the full picture.
No, 2252 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 28, 2025, the company has 450 employees. See our rating of the largest employees — is SHANGHAI MICROPORT MEDBOT (GROUP) C on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SHANGHAI MICROPORT MEDBOT (GROUP) C EBITDA is ‪−398.87 M‬ HKD, and current EBITDA margin is −143.00%. See more stats in SHANGHAI MICROPORT MEDBOT (GROUP) C financial statements.
Like other stocks, 2252 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHANGHAI MICROPORT MEDBOT (GROUP) C stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHANGHAI MICROPORT MEDBOT (GROUP) C technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHANGHAI MICROPORT MEDBOT (GROUP) C stock shows the buy signal. See more of SHANGHAI MICROPORT MEDBOT (GROUP) C technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.